This protocol is judged by an institutional critique board, an unbiased team that evaluations any medical trials involving humans. If a review requires a Plan I drug, as soon as the board approves the protocol as ethical, the scientists need to submit an application for an investigational new drug (IND) quantity from your FDA.copyright initial bec